Deregulating iron-erythropoiesis regulation: transferrin receptor 2 as potential target for treating anemia in CKD
Kidney International · 2023
DOI: 10.1016/j.kint.2023.04.017 ↗Kurz gefasst
Kommentar in der Zeitschrift Kidney International, 2023. Verfasst von Mark J Koury und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA; Medical Service, Depart…. Hauptthemen laut MEDLINE: Anemia, Erythropoietin, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Gefördert von: BLRD VA, NIDDK NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Both insufficient kidney production of erythropoietin and inflammation-mediated reduction of transferrin-bound iron are major factors in anemia of chronic kidney disease. Improved therapies for anemia in chronic kidney disease may involve modifying regulators of erythropoiesis and iron availability. Olivari et al. show in a mouse model of chronic kidney disease that transferrin receptor 2 in hepatocytes, where it is required for hepcidin production, and in erythroid cells, where it downregulates erythropoietin receptor activity, is a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA; Medical Service, Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashvill…
- Medical Service, Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, Tennessee, USA; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University School of Medicine,…
Förderung
- BLRD VA
- NIDDK NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- U.S. Department of Veterans Affairs
- Vanderbilt University
Zitieren
APA
Koury, M. J., & Haase, V. H. (2023). Deregulating iron-erythropoiesis regulation: transferrin receptor 2 as potential target for treating anemia in CKD. Kidney International. https://doi.org/10.1016/j.kint.2023.04.017
Vancouver
Koury MJ, Haase VH. Deregulating iron-erythropoiesis regulation: transferrin receptor 2 as potential target for treating anemia in CKD. Kidney International. 2023. doi:10.1016/j.kint.2023.04.017
BibTeX
@article{Koury2023,
author = {Koury, Mark J and Haase, Volker H},
title = {Deregulating iron-erythropoiesis regulation: transferrin receptor 2 as potential target for treating anemia in CKD},
journal = {Kidney International},
year = {2023},
doi = {10.1016/j.kint.2023.04.017}
}
EUVIMED